Charles Sermon
Founder presso MEREO BIOPHARMA GROUP PLC
Provenienza dei contatti di primo grado di Charles Sermon
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 33 | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK.
14
| Private Company | Investment Managers | 14 |
Rainbow Trust Children's Charity
 Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Rainbow Trust Children's Charity is engages in the provision of emotional and practical support for the families of children with life-threatening and terminal illnesses. It offers family, sibling, bereavement, transportation, and hospital support, aiming to maintain a normal family life. The company was founded by Bernadette Cleary in 1986 and is headquartered in Leatherhead, the United Kingdom.
9
| Non-Profit Organization | Miscellaneous Commercial Services | 9 |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The private company is based in London, UK and was founded in 2015.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The private company is based in London, UK.
3
| Subsidiary | Biotechnology | 3 |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The private company is based in London, UK.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Charles Sermon tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | General Counsel | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member President General Counsel Corporate Officer/Principal | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| Suffolk University | College/University | Undergraduate Degree | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of British Columbia | College/University | Graduate Degree Doctorate Degree | |
| University of Connecticut | College/University | Undergraduate Degree | |
| University Of Dundee | College/University | Doctorate Degree | |
| University of Mumbai | College/University | Graduate Degree Undergraduate Degree | |
| University of Durham | College/University | Graduate Degree Undergraduate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| Heriot-Watt University | College/University | Doctorate Degree | |
| The University of Sheffield | College/University | Undergraduate Degree Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | General Counsel | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| King's College London | College/University | Doctorate Degree | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| The Royal College of Surgeons of Edinburgh | College/University | Corporate Officer/Principal | |
| Baines Peter Consulting | Director/Board Member | ||
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 23 |
| Stati Uniti | 18 |
| India | 5 |
| Canada | 2 |
| Austria | 2 |
Settori
| Health Technology | 33 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 345 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 74 |
| Chairman | 65 |
| Chief Executive Officer | 40 |
Contatti più connessi
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Paul Blackburn | 46 |
| Frank Armstrong | 41 |
| Timothy Bunting | 38 |
| Deepa Pakianathan | 32 |
| Michael Wyzga | 31 |
| Anders Olof Adolf Ekblom | 27 |
| Judith Ann Hemberger | 26 |
| John P. Richard | 24 |
| David Chiswell | 23 |
| Peter John Fellner | 21 |
| Denise Scots-Knight | 20 |
| Peter Bains | 19 |
| Kunal Ashok Kashyap | 16 |
| Richard Jones | 15 |
- Borsa valori
- Insiders
- Charles Sermon
- Connessioni Società
